AI / ML INNOVATIONS INC - AIMLF STOCK NEWS

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced a collaboration between its subsidiary, Health Gauge Inc., and TaqTik Health, Inc. to pilot an AI-enhanced remote monitoring solution for obesity patients. The pilot, involving bariatric surgeons in Mexico and Asia, aims to support lifestyle modification and weight loss for patients post-surgery. TaqTik, serving over 35,000 remote obesity patients, will leverage Health Gauge's digital health platform to enhance patient outcomes. The partnership highlights the growing global obesity crisis, with obesity rates tripling since 1975, impacting approximately one billion people by 2030.

AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) announced the successful closing of its warrant exercise incentive program, encouraging the exercise of 5,648,000 unlisted common share purchase warrants. A total of 2,420,000 Eligible Warrants were exercised, resulting in proceeds of $181,500 for general working capital. Each holder also received an additional warrant, valid until January 9, 2024, for a Common Share at $0.10. The program aims to enhance liquidity and shareholder value as the company expands in the AI and digital health sectors.

AI/ML Innovations Inc. (AIMLF) has announced the launch of its subsidiary Tech2Heal SAS's Alakin ARPC Platform, a comprehensive solution for remote patient care. This 'third-generation' platform enhances patient engagement and streamlines workflows for healthcare providers, addressing limitations found in conventional monitoring systems. Alakin, which complies with HIPAA and supports FHIR standards, offers features such as telemedicine, scheduling management, and a multilingual mobile app. Its flexibility accommodates various healthcare settings, from oncology to primary care, ultimately aiming to improve patient outcomes.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced on January 4, 2023, that its subsidiary, Health Gauge Inc., is considering enforcement actions regarding its patent rights for a personal health monitoring solution. The company holds US Patent No. 11183303, which covers multiple wearable health monitor configurations and methods for analyzing health metrics. Tim Daniels, Chairman, indicated potential infringement by industry participants, highlighting the significant market value of wearable health tech in the US, estimated at several billion dollars annually.

AI/ML Innovations Inc. has engaged Octagon Media Corp for a four-month marketing services agreement to support its digital media campaign. The agreement involves a payment of US$60,000, compensated through 800,000 common shares at CAD$0.10 each. Additionally, Octagon will receive options to purchase 300,000 shares at CAD$0.20. AI/ML focuses on AI and ML technologies for healthcare solutions, with investments in companies like Health Gauge and AI Rx Inc..

AI/ML Innovations Inc. has launched a warrant exercise incentive program to encourage the early exercise of up to 5,648,000 common share purchase warrants. This initiative aims to boost working capital through the exercise of Series 'B' and Series 'D' Warrants with repriced prices of $0.075 and $0.20, respectively. The early exercise period runs from December 19, 2022, to January 9, 2023. The company anticipates gross proceeds of up to $423,600 and plans to issue additional incentive warrants. The program requires approval from the Canadian Securities Exchange.

AI/ML Innovations Inc. (AIMLF) has announced the acquisition of the remaining 30% of Health Gauge Inc. (HGI) for 1,800,000 Incentive Warrants. AIML previously acquired 70% of HGI in August 2020, making this transaction significant for full ownership. The acquisition aligns with AIML's focus on advancing AI and machine learning in digital healthcare. The deal is subject to Exchange approval and aims to enhance AIML's capabilities in personal health monitoring systems.

AI/ML Innovations Inc. (CSE:AIML; OTCQB:AIMLF) announced that the British Columbia Securities Commission has lifted the Management Cease Trade Order (MCTO) previously imposed on August 30, 2022. This decision follows the successful completion of the required filings for its annual and interim financial statements. The MCTO had delayed the company's trading activities due to late filings associated with a significant equity investment in Tech2Heal SAS. The company expressed gratitude to its shareholders and regulators, ensuring its commitment to financial transparency.

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced a delay in filing its financial documents, resulting in a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) effective August 30, 2022. The CEO and CFO are restricted from trading until the annual audited financial statements are filed. The company aims to file the necessary documents by October 28, 2022, while addressing accounting issues related to a France-based investee. It will continue issuing bi-weekly default status reports during this period.